MedTrace Logo

18F-GP1 PET-CT to Detect Bioprosthetic Aortic Valve Thrombosis

NCT04073875 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2024-09-19

No results posted yet for this study

Summary

18F-GP1 binds with high affinity to the glycoprotein IIb/IIIa receptors on activated platelets. 18F-GP1 PET-CT has recently demonstrated favourable safety, pharmacokinetic, biodistribution and diagnostic performance for the in vivo identification of venous and arterial thrombemboli.

Conditions

  • Thrombosis Cardiac
  • Aortic Valve Disease

Interventions

DIAGNOSTIC_TEST

18F-GP1

18F-GP1 PET-CT scan

Sponsors & Collaborators

  • Life Molecular Imaging SA

    collaborator INDUSTRY

  • British Heart Foundation

    collaborator OTHER

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • David E Newby, MD · University of Edinburgh

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-22
Primary Completion
2021-10-13
Completion
2021-10-13

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04073875 on ClinicalTrials.gov